Detalhe da pesquisa
1.
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications.
BMC Public Health;
19(1): 645, 2019 May 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31138232
2.
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
BMC Infect Dis;
18(1): 683, 2018 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30567494
3.
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects.
Infection;
50(2): 541-543, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34342854
4.
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort.
Viruses;
15(1)2023 01 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36680233
5.
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses.
Vaccines (Basel);
10(8)2022 Aug 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36016125
6.
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
Int J Infect Dis;
108: 176-178, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34022329
7.
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects.
Life (Basel);
11(9)2021 Aug 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34575045
8.
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
Int J Infect Dis;
112: 40-44, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34481967
9.
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection.
Open Forum Infect Dis;
8(7): ofab312, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34295945
10.
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort.
Microorganisms;
9(2)2021 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33671934
11.
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection.
Sci Rep;
11(1): 9274, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33927306
12.
Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019.
Int J Infect Dis;
92: 81-88, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31935535
13.
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection.
Ann Gastroenterol;
30(5): 534-541, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28845109
14.
Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study.
Eur J Gastroenterol Hepatol;
33(1S Suppl 1): e1076-e1077, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35048665
15.
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia.
Health Sci Rep;
4(1): e221, 2021 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33364441